Cara Therapeutics, Inc.
CARADrugs in Pipeline
10
Phase 3 Programs
4
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
CR845 IV 1 mcg/kg
Post Abdominal Surgery Pain
CR845 1 mcg/kg
Uremic Pruritus
CR845
Postoperative Pain
CR845 0.5 mcg/kg
Uremic Pruritus
difelikefalin 0.25 mg
Pruritus
difelikefalin 2.0 mg
Pruritus
Part A: CR845 0.5 mcg/kg
Pruritus
CR845 0.25 mg Oral Tablet
Chronic Kidney Diseases
CR845 0.25 mg
Osteoarthritis
CR845 tablet 1 mg
Osteoarthritis, Hip
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
CR845 IV 1 mcg/kg | Phase 3 | Post Abdominal Surgery Pain | - | - |
CR845 1 mcg/kg | Phase 3 | Uremic Pruritus | - | - |
CR845 | Phase 3 | Postoperative Pain | - | - |
CR845 0.5 mcg/kg | Phase 3 | Uremic Pruritus | - | - |
difelikefalin 0.25 mg | Phase 2 | Pruritus | - | - |
difelikefalin 2.0 mg | Phase 2 | Pruritus | - | - |
Part A: CR845 0.5 mcg/kg | Phase 2 | Pruritus | - | - |
CR845 0.25 mg Oral Tablet | Phase 2 | Chronic Kidney Diseases | - | - |
CR845 0.25 mg | Phase 2 | Osteoarthritis | - | - |
CR845 tablet 1 mg | Phase 2 | Osteoarthritis, Hip | - | - |
Pruritus
3 drugs in this indication
Uremic Pruritus
3 drugs in this indication
Postoperative Pain
1 drug in this indication
Post Abdominal Surgery Pain
1 drug in this indication
Osteoarthritis, Hip
1 drug in this indication
Chronic Kidney Diseases
1 drug in this indication
Osteoarthritis
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in Cara Therapeutics, Inc.'s drug pipeline?→
CatalystAlert tracks 10 drug candidates in Cara Therapeutics, Inc.'s (CARA) pipeline across Phase 3, Phase 2. Its lead program is CR845 IV 1 mcg/kg (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Cara Therapeutics, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Cara Therapeutics, Inc. (CARA) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track CARA biotech catalysts?→
Add CARA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Cara Therapeutics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.